• Home
  • Sonja Šelemetjev

Sonja Šelemetjev

Organisation Group: Department for Endocrinology and Radioimmunology

Academic Degree: Graduated in Biochemistry, PhD in Molecular biology

Current position: Research Associate

Education: Graduated at Faculty of Chemistry, University of Belgrade in 2004. M. Sc Thesis in Biochemistry finished in 2008. and PhD Thesis in 2014. at Faculty of Biology, University of Belgrade.

Research Field:

Part of the group investigating function and growth of thyroid gland, both in physiological and pathophysiological conditions. The activities focus on the molecular pathogenesis of malignant thyroid tumors.

Membership in International and National Societies:

Member of the Serbian Chemical Society
Member of the Biochemical Society
Member of the European Thyroid Association

Bibliography (2013-2018):

Rončević J, Đorić I, Šelemetjev S, Janković J, Išić Denčić T, Božić V, Cvejić D. MMP-9 -1562 C/T single nucleotide polymorphism associates with increased MMP-9 level and activity during papillary thyroid carcinoma progression. Pathology, 2018, doi: 10.1016/j.pathol.2018.10.008.

Denčić Išić T, Bartolome A, Šelemetjev S, Đorić I, Tatić S, Živaljević V, Cvejić D. High expression and localization of β-catenin and epidermal growth factor receptor identify high risk papillary thyroid carcinoma patients. Experimental and Molecular Pathology, 2018, 105:181-189.

Šelemetjev S, Bartolome A, Išić Denčić T, Đorić I, Paunović I, Tatić S, Cvejić D. Overexpression of EGF receptor and its downstream effector, focal adhesion kinase (FAK), correlates with papillary thyroid carcinoma progression. International Journal of Experimental Pathology, 2018, 99:87-94.

Šelemetjev S, Savin S, Paunović S, Tatić S, Cvejić D. Concomitant high expression of survivin and vascular endothelial growth factor-C is strongly associated with metastatic status of lymph nodes in papillary thyroid carcinoma. Journal of Cancer Research and Therapeutics, 2018, 14: 114-119.

Šelemetjev S, Ðorić I, Paunović I, Tatić S, Cvejić D. Coexpressed High Levels of VEGF-C and Active MMP-9 Are Associated With Lymphatic Spreading and Local Invasiveness of Papillary Thyroid Carcinoma. American Journal of Clinical Pathology, 2016, 146:594-602.

Denčić TM, Savin SB, Šelemetjev SA, Paskaš SD, Živaljević VR, Božić VD, Cvejić DS. Strong expression of HBME-1 associates with high-risk clinicopathological factors of papillary thyroid carcinoma. Pathology and Oncology Research, 2015, 21:735-742.

Šelemetjev SA, Savin SB, Paunović IR, Tatić SB, Cvejić D. Changes in the expression pattern of apoptotic molecules (galectin-3, Bcl-2, Bax, survivin) during progression of thyroid malignancy and their clinical significance. Wiener Klinische Wochenschrift, 2015, 127:337-344.

Marečko I, Cvejić D, Šelemetjev S, Paskaš S, Tatić S, Paunović I, Savin S. Enhanced activation of matrix metalloproteinase-9 correlates with the degree of papillary thyroid carcinoma infiltration. Croatian Medical Journal, 2014, 55:128-37.

Šelemetjev S, Denčić TI, Marečko I, Janković J, Paunović I, Savin S, Cvejić D. Evaluation of survivin expression and its prognostic value in papillary thyroid carcinoma. Pathology Research and Practice, 2014, 210:30-34.